Ep. 122: Tesla accounting, Adaptive Biotech’s cancer blood test, IBM and AutoNation

from The Drill Down · host Cory Johnson

A blood test for cancer? Adaptive Biotech founders Chad and Harlan Robins explain. (Yes, they’re brothers!) (ADPT) Tesla’s novel accounting treatment for non-existent Full Self Driving Cars (TSLA). AutoNation says car shortages will persist through 2023 (AN). The Incredible Shrinking IBM. The Drill Down with Cory Johnson offers a daily look at the business stories behind stocks on the move. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published Oct 21, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Ep. 122: Tesla accounting, Adaptive Biotech’s cancer blood test, IBM and AutoNation

0:00 48:09

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Drill Down?

This episode is 48 minutes long.

When was this The Drill Down episode published?

This episode was published on October 21, 2021.

Can I download this The Drill Down episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!